摘要
目的:研究评价法莫替丁缓释片在健康人体内的生物利用度。方法:以高效液相色谱法测定血药浓度,用3P87程序处理数据。结果:单剂量给药,本品的达峰时间为(7.12±0.40)h,峰浓度为(58.69±4.36)ng·ml-1,相对生物利用度为(117.0±8.9)%;多剂量给药达稳态后,本品的峰浓度为(70.72±4.61)ng·ml-1,血药浓度波动度为(121.6±11.4)%,相对生物利用度为(117.9±23.46)%。结论:法莫替丁缓释片与市售普通片基本生物等效。
OBJECTIVE: The bioavailability of famotidine sustainedrelease tablets was studied in 16 healthy volunteers. METHODS:BZThe famotidine plasma levels were determined by HPLC method,and the plasma leveltime data were proessed by 3P87 pharmacokinetics procedure. RESULTS: The results showed that the peak plasma level occurring at(7.120.40)h was (58.694.30)ngml-1,and its relative bioavailability was (117.08.9)% after a single dose oral administration;The peak pasma level was (70.724.61)ngml-1,the fluctuating degree (FD) was (121.611.4)%,and its relative bioavailability was (117.923.46)% at steady state after multiple dose oral administration. CONCLUSION: The effect of the sustainedrelease tablets is basically equivalent to that of the normal tablets on marketing.
出处
《中国药学杂志》
CAS
CSCD
北大核心
1999年第8期545-549,共5页
Chinese Pharmaceutical Journal
关键词
法莫替丁
缓释片
生物利用度
famotidine,sustainedrelease tablets,pharmacokinetics,bioavailability,HPLC